Ahmed Mahmoud: Triple Versus Double Antithrombotic Therapy After PCI in Atrial Arrhythmia
Ahmed Mahmoud, Researcher at Negida Research Rcademy, shared a post on LinkedIn about a recent article by Khaled Elnaggar et al., published in Future Cardiology, adding:
“Proud to share our team’s newly published article in Future Cardiology:
Triple versus double anti thrombotic therapy after PCI in atrial arrhythmia.
Using real-world TriNetX data, our study found that initial triple therapy was associated with higher adverse clinical outcomes compared with double therapy after PCI in patients with atrial fibrillation or flutter.
Congratulations to the entire team on this important collaborative work.”
Title: Triple versus double antithrombotic therapy after PCI in atrial arrhythmia: a real-world comparative analysis based on initial antithrombotic strategy using TriNetx
Authors: Khaled Elnaggar, Mohammad Hamza, Saif Ali Malik, Kyrillos Mahrous Gerges, Saira Shafiq, Meet Patel, Ali Awad, Roopeessh Vempati, Haidar Hajeh, Muhammad Burhan, Yassine Abdeldjebbar, M Chadi Alraies
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge